Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000664712 | SCV000788716 | likely benign | Alstrom syndrome | 2017-01-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000664712 | SCV001706492 | likely benign | Alstrom syndrome | 2024-10-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002369790 | SCV002686739 | likely benign | Cardiovascular phenotype | 2019-05-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV003128684 | SCV003805338 | uncertain significance | not provided | 2022-08-12 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |